CNS Financial Statements From 2010 to 2026
| CNSP Stock | | | USD 4.27 0.24 5.32% |
Analyzing historical trends in various income statement and balance sheet accounts from CNS Pharmaceuticals' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CNS Pharmaceuticals' valuation are summarized below:
Market Capitalization | Earnings Share |
There are currently one hundred twenty fundamental signals for CNS Pharmaceuticals that can be evaluated and compared over time across rivals. Investors and active traders are advised to validate CNS Pharmaceuticals' prevailing fundamental performance against the performance between
2010 and 2026 to make sure the trends are evolving in the right direction.
Check out the analysis of
CNS Pharmaceuticals Correlation against competitors.
To learn how to invest in CNS Stock, please use our
How to Invest in CNS Pharmaceuticals guide.
CNS Pharmaceuticals Balance Sheet | | |
|
CNS Pharmaceuticals Income Statement | | |
|
CNS Pharmaceuticals Cash Flow Statement | | |
|
Financial Ratios | | |
|
CNS Pharmaceuticals Valuation Data | | |
|
CNS Fundamental Market Drivers
CNS Upcoming Events
About CNS Pharmaceuticals Financial Statements
CNS Pharmaceuticals shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although CNS Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in CNS Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on CNS Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our
fundamental analysis page.
Pair Trading with CNS Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CNS Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CNS Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to CNS Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CNS Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CNS Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CNS Pharmaceuticals to buy it.
The correlation of CNS Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CNS Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CNS Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CNS Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Additional Tools for CNS Stock Analysis
When running CNS Pharmaceuticals' price analysis, check to
measure CNS Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CNS Pharmaceuticals is operating at the current time. Most of CNS Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of CNS Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CNS Pharmaceuticals' price. Additionally, you may evaluate how the addition of CNS Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.